Real-time fluorescence monitoring of phenothiazinium photosensitizers and their anti-mycobacterial photodynamic activity against Mycobacterium bovis BCG in in vitro and in vivo models of localized infection

Photochemical and Photobiological Sciences

Volumn 6, Issue 10, 2007, Pages 1117-1123

  O'Riordan, Katie ^a   Akilov, Oleg E ^a   Chang, Sung K ^a   Foley, James W ^b   Hasan, Tayyaba ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 ETHYLAMINO 9 DIETHYLAMINOBENZO[A]PHENOSELENAZINIUM CHLORIDE; 5 ETHYLAMINO 9 DIETHYLAMINOBENZO[A]PHENOTHIAZINIUM CHLORIDE; ANTIINFECTIVE AGENT; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLUORESCENCE; GRANULOMA; MALE; MICROSCOPY; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

MURINAE; MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG;

EID: 34948861090     PISSN: 1474905X     EISSN: 14749092     Source Type: Journal    
DOI: 10.1039/b707962a     Document Type: Article

References (36)

1. M. R. Hamblin T. Hasan Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci. 2004 3 436 450
2. G. P. Tegos M. R. Hamblin Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps Antimicrob. Agents Chemother. 2006 50 196 203
3. S. B. Brown, Clinical studies using antimicrobial PDT, in 11th World Congress of the International Photodynamic Association, Shanghai, China, 2007, p. 51
4. K. O'Riordan O. E. Akilov T. Hasan The potential for photodynamic therapy in the treatment of localized infections Photodiagn. Photodyn. Ther. 2005 2 247 262
5. T. Hasan, B. Ortel, A. C. E. Moor and B. W. Pogue, Chapter 40. Photodynamic therapy of cancer, in Cancer Medicine, ed., H. Frei,, BC Dekker, Inc., New York, NY, USA, 2003, pp. 605-622
6. A. P. Castano T. N. Demidova M. R. Hamblin Mechanisms in photodynamic therapy: Part One - Photosensitizers, photochemistry and cellular localization Photodiagn. Photodyn. Ther. 2004 1 279 293
7. G. Jori S. B. Brown Photosensitized inactivation of microorganisms Photochem. Photobiol. Sci. 2004 3 403 405
8. T. Maisch R. M. Szeimies G. Jori C. Abels Antibacterial photodynamic therapy in dermatology Photochem. Photobiol. Sci. 2004 3 907 917
9. S. B. Brown, Antimicrobial PDT: we have heard the theory, what about the practice? in The 11th Congress of the European Society for Photobiology, ed., J. Piette,, Aix-les-Bains, France, 2005, p. 100
10. K. O'Riordan D. S. Sharlin J. Gross S. Chang D. Errabelli O. E. Akilov S. Kosaka G. J. Nau T. Hasan Photoinactivation of Mycobacteria in vitro and in a new murine model of localized Mycobacterium bovis BCG-induced granulomatous infection Antimicrob. Agents Chemother. 2006 50 1828 1834
11. M. S. Glickman W. R. Jacobs, Jr. Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline Cell 2001 104 477 485
12. M. D. Iseman MDR-TB and the developing world-a problem no longer to be ignored: the WHO announces 'DOTS Plus' strategy Int. J. Tuberc. Lung Dis. 1998 2 867
13. E. Nathanson R. Gupta P. Huamani V. Leimane A. D. Pasechnikov T. E. Tupasi K. Vink E. Jaramillo M. A. Espinal Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative Int. J. Tuberc. Lung Dis. 2004 8 1382 1384
14. P. Godfrey-Faussett H. Ayles Can we control tuberculosis in high H prevalence settings? Tuberculosis 2003 83 68 76
15. P. Ravn M. E. Munk A. B. Andersen B. Lundgren L. N. Nielsen T. Lillebaek I. J. Soerensen P. Andersen K. Weldingh Reactivation of tuberculosis during immunosuppressive treatment in a patient with a positive QuantiFERON-RD1 test Scand. J. Infect. Dis. 2004 36 499 501
16. M. I. Perelman V. P. Strelzov Surgery for pulmonary tuberculosis World J. Surg. 1997 21 457 467
17. C. E. Millson M. Wilson A. J. MacRobert S. G. Bown Ex vivo treatment of gastric Helicobacter infection by photodynamic therapy J. Photochem. Photobiol., B 1996 32 59 65
18. M. Wainwright The development of phenothiazinium photosensitisers Photodiagn. Photodyn. Ther. 2005 2 263 272
19. L. Cincotta D. Szeto E. Lampros T. Hasan A. H. Cincotta Benzophenothiazine and benzoporphyrin derivative combination phototherapy effectively eradicates large murine sarcomas Photochem. Photobiol. 1996 63 229 237
20. D. A. Phoenix Z. Sayed S. Hussain F. Harris M. Wainwright The phototoxicity of phenothiazinium derivatives against Escherichia coli and Staphylococcus aureus FEMS Immunol. Med. Microbiol. 2003 39 17 22
21. M. N. Usacheva M. C. Teichert M. A. Biel The role of the methylene blue and toluidine blue monomers and dimers in the photoinactivation of bacteria J. Photochem. Photobiol., B 2003 71 87 98
22. M. Wainwright D. A. Phoenix S. L. Laycock D. R. Wareing P. A. Wright Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus FEMS Microbiol. Lett. 1998 160 177 181
23. M. Wainwright D. A. Phoenix J. Marland D. R. Wareing F. J. Bolton A study of photobactericidal activity in the phenothiazinium series FEMS Immunol. Med. Microbiol. 1997 19 75 80
24. J. W. Foley X. Song T. N. Demidova F. Jalil M. R. Hamblin Synthesis and Properties of Benzo[a]phenoxazinium Chalcogen Analogues as Novel Broad-Spectrum Antimicrobial Photosensitizers J. Med. Chem. 2006 49 7252
25. O. E. Akilov S. Kosaka K. O'Riordan X. Song M. Sherwood T. J. Flotte J. W. Foley T. Hasan The Role of Photosensitizer Molecular Charge and Structure on the Efficacy of Photodynamic Therapy against Leishmania Parasites Chem. Biol. 2006 13 839 847
26. L. Amaral J. E. Kristiansen M. Viveiros J. Atouguia Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis: a review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy J. Antimicrob. Chemother. 2001 47 505 511
27. D. Ordway M. Viveiros C. Leandro R. Bettencourt J. Almeida M. Martins J. E. Kristiansen J. Molnar L. Amaral Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis Antimicrob. Agents Chemother. 2003 47 917 922
28. Y. Zhang The magic bullets and tuberculosis drug targets Annu. Rev. Pharmacol. Toxicol. 2005 45 529 564
29. F. A. Salih N. K. Kaushik P. Sharma G. V. Choudary P. S. Murthy T. A. Venkitasubramanian Calmodulin-like activity in mycobacteria Indian J. Biochem. Biophys. 1991 28 491 495
30. J. T. Groves S. M. Lindenauer B. J. Haywood J. A. Knol J. S. Schultz Synthesis of seleno-toluidine blue J. Med. Chem. 1974 17 902 904
31. M. J. Hickey T. M. Arain R. M. Shawar D. J. Humble M. H. Langhorne J. N. Morgenroth C. K. Stover Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice Antimicrob. Agents Chemother. 1996 40 400 407
32. K. I. Moller B. Kongshoj P. A. Philipsen V. O. Thomsen H. C. Wulf How Finsen's light cured lupus vulgaris Photodermatol. Photoimmunol. Photomed. 2005 21 118 124
33. S. G. Bown A. Z. Rogowska New photosensitizers for photodynamic therapy in gastroenterology Can. J. Gastroenterol. 1999 13 389 392
34. S. Kosaka O. E. Akilov K. O'Riordan T. Hasan A mechanistic study of δ-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis J. Invest. Dermatol. 2007 127 1546 1549
35. O. E. Akilov S. Kosaka K. O'Riordan T. Hasan Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells Exp. Dermatol. 2007 16 651 660
36. L. Cincotta J. W. Foley A. H. Cincotta Phototoxicity, redox behavior, and pharmacokinetics of benzophenoxazine analogues in EMT-6 murine sarcoma cells Cancer Res. 1993 53 2571 2580